Abstract:The vascular cognitive impairment no dementia (VCIND) is a very early, mild, and highly insidious stage of vascular cognitive impairment (VCI), which is the most common form of VCI in the elderly. VCI is not a single disease, but refers to a syndrome of mild cognitive impairment (MCI) to dementia caused by risk factors for cerebrovascular disease (CVD), obvious or unclear CVDs. Its clinical manifestations are very complex, mainly including impairment in memory, execution ability, attention, language, emotions, personality, and other aspects. VCIND is considered a pre dementia state. Scholars have found during follow-up that nearly 34% of patients develop dementia, and 14% of patients return to normal cognitive impairment (CI). It can be seen that the risk of VCIND developing into dementia is high, but not all patients will develop into dementia, and the condition is reversible. MCI is an intermediate transitional state between normal aging and early dementia. According to the presence or absence of memory impairment, MCI can be divided into amnestic MCI (aMCl) and non-amnestic MCI (naMCI). [ 1 , 2 ] aMCI generally progresses to Alzheimer disease (AD), while naMCI mostly progresses to vascular dementia (VD), frontotemporal dementia (FTD), and body lewy dementia (DLB). Making correct judgments about aMCI and naMCI as early as possible will effectively guide clinical treatment and improve prognosis. In the study of CI diseases, the region of interest of 1 H-MRS is mainly located in anatomical regions related to cognitive function, such as the frontal lobe (FL), hippocampus, cingulate gyrus, and other parts. The hippocampus has been proven to be related to memory ability and plays a very important role in memory storage and retrieval. [ 3 ] However, the hippocampus is highly susceptible to damage due to ischemia and hypoxia. There are literature reports that the most sensitive cells to ischemia and hypoxia are a type of conical cell located in the hippocampus. When the hippocampus is damaged, the concentration level of NAA changes, which is significantly correlated with memory ability. [ 4 ] In cognitive dysfunction diseases, the hippocampus is the earliest and most prone to pathological changes. [ 5 ] So while the exact pathogenesis of vascular CI still needs further research. Early monitoring of the hippocampus, which is associated with various cognitive disorders, may be helpful for the judgment and mechanism understanding of cognitive states. The comprehensive application of technologies and methods such as neuroimaging and neuropsychological assessment to study the relationship between CVD and CI has become an important research approach in this field. This study utilized 1 H-MRS to investigate whether there are cellular level metabolic variations in the hippocampus of VCIND cases, and analyzed the characteristics of changes in 1 H-MRS metabolite parameters in the hippocampus of patients and their relationship with diseases. The purpose is to provide valuable imaging evidence for the early diagnosis and treatment of VCIND, aMCI, and naMCI patients.

Amide proton transfer could be a surrogate imaging marker for predicting vascular cognitive impairment

Aggregation of Vascular Risk Factors Modulates the Amplitude of Low-Frequency Fluctuation in Mild Cognitive Impairment Patients

Decreased Bilateral FDG-PET Uptake and Inter-Hemispheric Connectivity in Multi-Domain Amnestic Mild Cognitive Impairment Patients: A Preliminary Study

Structural and functional activities of brain in patients with vascular cognitive impairment: A case-controlled magnetic resonance imaging study

Deep Medullary Veins: a Promising Neuroimaging Marker for Mild Cognitive Impairment in Outpatients

Utility of cerebrovascular imaging biomarkers to detect cerebral amyloidosis

Altered neurovascular coupling in patients with vascular cognitive impairment: a combined ASL-fMRI analysis

Neuroinflammation and amyloid deposition in the progression of mixed Alzheimer and vascular dementia

Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers

Potential Clinical Value of Multiparametric PET in the Prediction of Alzheimer’s Disease Progression

Characteristic early changes of Glu and Cho in brain regions affected by different types of subjective cognitive decline and their clinical significance

Multi-Dimensional Diffusion Tensor Imaging Biomarkers for Cognitive Decline From the Preclinical Stage: A Study of Post-stroke Small Vessel Disease

Evaluation of Functional Mri Markers in Mild Cognitive Impairment

Imaging Biomarkers of VCI: A Focused Update

Correlation between Imaging of Cholinergic Pathways Impairment and Cognition in Cerebral Small Vessel Disease

18 F-FDG PET and a Classifier Algorithm Reveal a Characteristic Glucose Metabolic Pattern in Adult Patients with Moyamoya Disease and Vascular Cognitive Impairment

Machine learning based on the EEG and structural MRI can predict different stages of vascular cognitive impairment

Application of 18F-AV45 PET Imaging in Subtle Cognitive Decline and Mild Cognitive Impairment Patients

Seeing beyond the symptoms: biomarkers and brain regions linked to cognitive decline in Alzheimer's disease

The Association Between Brain Metabolic Biomarkers Using 18F-FDG and Cognition and Vascular Risk Factors, as well as Its Usefulness in the Diagnosis and Staging of Alzheimer's Disease

Analysis of Factors Affecting Cranial Nerve Function of Patients With Vascular Mild Cognitive Impairment Through Functional Magnetic Resonance Imaging Under Artificial Intelligence Environment